Home
Contributors
Glossary
Subscribe

Bioasis Technologies Inc.

The Science of Melanotransferrin (p97)

From the category archives:

ADDL

New Studies Support Link Between Diabetes and Alzheimer’s Disease

by Christine on February 10, 2009

Pages
Recent Posts
Categories
- ADDL (1)
- age-related neurodegenerative disease (150)
- Alzheimer's Research (194)
- amyloid beta deposits/plaques (64)
- amyloid protein vaccination (4)
- antidepressants (4)
- axon deterioration (53)
- BioAsis (106)
- biosecurity (1)
- biosimilar therapies (23)
- biotechnology (151)
- bioterrorism (1)
- Blood Brain Barrier (53)
- CEO (2)
- cholinergic effects (1)
- chronic neurological diseases (81)
- Citizen Petition (4)
- dementia (71)
- diabetes (5)
- DNA (5)
- Dr. Wilf Jefferies (3)
- FDA (14)
- Frontotemporal Dementia (19)
- Genentech (9)
- Health reform (17)
- Huntington's Disease (11)
- Huntington’s Disease (5)
- immunotherapy (1)
- LDT (1)
- Lewy Body Variant (5)
- Melanotransferrin (64)
- mental illness (51)
- MOCA (2)
- Neurological Diseases (163)
- neurological disorders (68)
- New Studies (18)
- Not-for-Profit Organisations (9)
- P97 (81)
- Parkinson's (22)
- Parkinson's Disease (32)
- Parkinson’s (8)
- personalized medicine (7)
- Pfizer (36)
- Pharma (31)
- prescription medicine (13)
- research cutbacks (31)
- Research tools (4)
- SEB (2)
- Subsequent Entry Biologics (2)
- tau tangles (30)
- team members (3)
- Uncategorized (29)
- Unconventional treatments (4)
- Vascular Dementia (23)
- Wyeth (21)

Recent Comments
Archives
- September 2010 (5)
- August 2010 (17)
- July 2010 (19)
- June 2010 (18)
- May 2010 (16)
- April 2010 (17)
- March 2010 (17)
- February 2010 (15)
- January 2010 (15)
- December 2009 (16)
- November 2009 (16)
- October 2009 (17)
- September 2009 (18)
- August 2009 (18)
- July 2009 (18)
- June 2009 (15)
- May 2009 (13)
- April 2009 (13)
- March 2009 (10)
- February 2009 (16)
- January 2009 (4)
- September 2008 (1)
Categories

Get smart with the Thesis WordPress Theme from DIYthemes.

WordPress Admin